HK Stock MarketDetailed Quotes

02120 KN HOSPITAL

Watchlist
  • 11.600
  • -0.080-0.68%
Not Open May 3 16:09 CST
865.36MMarket Cap9.13P/E (TTM)

KN HOSPITAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Cash flow from operating activities
Profit adjustment
Impairment and provisions:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Revaluation surplus:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Asset sale loss (gain):
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Depreciation and amortization:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Operating profit before the change of operating capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Change of operating capital
Cash  from business operations
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net cash from operations
16.64%265.03M
102.93%113.59M
17.19%227.22M
50.00%55.97M
-2.88%193.9M
109.65%37.32M
79.40%199.66M
328.14%17.8M
67.30%111.29M
-83.63%4.16M
Cash flow from investment activities
Sale of fixed assets
-87.86%2.92M
-99.86%26.38K
175.27%24.1M
18.67%19.04M
126.18%8.76M
314.47%16.04M
-88.24%3.87M
--3.87M
--32.92M
----
Purchase of fixed assets
24.13%-179.73M
10.96%-107.84M
-32.70%-236.91M
-45.13%-121.12M
5.01%-178.54M
-24.42%-83.46M
-47.36%-187.96M
-6.30%-67.08M
12.34%-127.54M
24.86%-63.1M
Sale of subsidiaries
----
----
----
----
----
--14.24M
----
----
--1.86M
--1.83M
Acquisition of subsidiaries
41.72%-31.29M
75.65%-15.19M
33.36%-53.69M
-271.90%-62.37M
-224.39%-80.56M
34.47%-16.77M
-4,395.11%-24.84M
-1,953.48%-25.59M
96.85%-552.51K
---1.25M
Recovery of cash from investments
--8.28M
--8.25M
----
----
6.37%52.12M
----
10,859.66%49M
6,612.22%30.01M
--447.09K
--447.1K
Cash on investment
---2.45M
---3.87M
----
----
-40.69%-48.6M
-98.09%-30M
28.71%-34.55M
-16.32%-15.15M
-92.36%-48.46M
22.45%-13.02M
Other items in the investment business
-79.10%-12.75M
---500.06K
-191.55%-7.12M
----
-4.53%7.78M
1,658.80%39.03M
931.96%8.15M
-214.68%-2.5M
-97.59%789.41K
97.48%-795.62K
Net cash from investment operations
21.42%-215.02M
27.57%-119.12M
-14.46%-273.62M
-169.96%-164.45M
-28.30%-239.05M
20.30%-60.92M
-32.58%-186.32M
-0.73%-76.44M
9.62%-140.53M
42.64%-75.88M
Net cash before financing
207.81%50.02M
94.90%-5.53M
-2.75%-46.39M
-359.62%-108.48M
-438.57%-45.15M
59.75%-23.6M
145.61%13.34M
18.24%-58.64M
67.13%-29.24M
32.90%-71.72M
Cash flow from financing activities
New borrowing
56.33%605.77M
-20.93%251.05M
-29.58%387.5M
12.19%317.5M
35.37%550.25M
-22.95%283M
50.55%406.49M
116.05%367.29M
41.78%270M
0.00%170M
Refund
-10.32%-357.68M
-25.55%-109.63M
24.31%-324.22M
39.73%-87.32M
-47.70%-428.34M
28.24%-144.89M
-56.76%-290M
-38.29%-201.9M
-9.28%-185M
-4.44%-146M
Dividends paid - financing
31.34%-35.4M
-23.33%-21.32M
-70.16%-51.55M
-44.24%-17.29M
-77.08%-30.3M
-45.46%-11.99M
41.07%-17.11M
-23.96%-8.24M
-56.11%-29.04M
-12.01%-6.65M
Absorb investment income
-67.23%3M
-29.58%2.85M
215.62%9.15M
65.24%4.04M
-87.59%2.9M
-89.53%2.45M
89.24%23.36M
450.33%23.36M
-64.55%12.35M
-4.18%4.25M
Other items of the financing business
-225.49%-119.59M
-413.20%-113.15M
257.06%95.3M
37.76%-22.05M
39.74%-60.68M
58.60%-35.43M
-66.30%-100.69M
-79.98%-85.56M
---60.55M
-1,501.60%-47.54M
Net cash from financing operations
-17.28%96.11M
-94.98%9.79M
243.38%116.18M
109.24%194.88M
53.42%33.83M
-1.90%93.14M
184.12%22.05M
466.00%94.95M
-79.23%7.76M
-200.80%-25.94M
Effect of rate
-94.49%4.33K
-70.50%13.07K
302.72%78.46K
310.66%44.31K
84.39%-38.7K
-118.02%-21.04K
60.97%-248.02K
115.39%116.74K
-157.04%-635.43K
-171.83%-758.6K
Net Cash
109.17%146.13M
-95.06%4.27M
715.09%69.86M
24.36%86.45M
-132.32%-11.36M
90.85%69.52M
258.90%35.14M
137.01%36.42M
56.18%-22.11M
-20.85%-98.42M
Begining period cash
37.02%258.6M
37.02%258.6M
-5.68%188.73M
-5.68%188.73M
21.30%200.09M
21.30%200.09M
-11.82%164.95M
-11.82%164.95M
-21.25%187.07M
-21.25%187.07M
Cash at the end
56.51%404.72M
-4.47%262.87M
37.02%258.6M
2.07%275.18M
-5.68%188.73M
33.88%269.61M
21.30%200.09M
127.17%201.38M
-11.82%164.95M
-43.21%88.64M
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Qualified opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Lixin Certified Public Accountants (special general partnership)
--
Lixin Certified Public Accountants (special general partnership)
--
Lixin Certified Public Accountants (special general partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Cash flow from operating activities
Profit adjustment
Impairment and provisions: --0--0--0--0--0--0--0--0--0--0
Revaluation surplus: --0--0--0--0--0--0--0--0--0--0
Asset sale loss (gain): --0--0--0--0--0--0--0--0--0--0
Depreciation and amortization: --0--0--0--0--0--0--0--0--0--0
Operating profit before the change of operating capital --0--0--0--0--0--0--0--0--0--0
Change of operating capital
Cash  from business operations --0--0--0--0--0--0--0--0--0--0
Net cash from operations 16.64%265.03M102.93%113.59M17.19%227.22M50.00%55.97M-2.88%193.9M109.65%37.32M79.40%199.66M328.14%17.8M67.30%111.29M-83.63%4.16M
Cash flow from investment activities
Sale of fixed assets -87.86%2.92M-99.86%26.38K175.27%24.1M18.67%19.04M126.18%8.76M314.47%16.04M-88.24%3.87M--3.87M--32.92M----
Purchase of fixed assets 24.13%-179.73M10.96%-107.84M-32.70%-236.91M-45.13%-121.12M5.01%-178.54M-24.42%-83.46M-47.36%-187.96M-6.30%-67.08M12.34%-127.54M24.86%-63.1M
Sale of subsidiaries ----------------------14.24M----------1.86M--1.83M
Acquisition of subsidiaries 41.72%-31.29M75.65%-15.19M33.36%-53.69M-271.90%-62.37M-224.39%-80.56M34.47%-16.77M-4,395.11%-24.84M-1,953.48%-25.59M96.85%-552.51K---1.25M
Recovery of cash from investments --8.28M--8.25M--------6.37%52.12M----10,859.66%49M6,612.22%30.01M--447.09K--447.1K
Cash on investment ---2.45M---3.87M---------40.69%-48.6M-98.09%-30M28.71%-34.55M-16.32%-15.15M-92.36%-48.46M22.45%-13.02M
Other items in the investment business -79.10%-12.75M---500.06K-191.55%-7.12M-----4.53%7.78M1,658.80%39.03M931.96%8.15M-214.68%-2.5M-97.59%789.41K97.48%-795.62K
Net cash from investment operations 21.42%-215.02M27.57%-119.12M-14.46%-273.62M-169.96%-164.45M-28.30%-239.05M20.30%-60.92M-32.58%-186.32M-0.73%-76.44M9.62%-140.53M42.64%-75.88M
Net cash before financing 207.81%50.02M94.90%-5.53M-2.75%-46.39M-359.62%-108.48M-438.57%-45.15M59.75%-23.6M145.61%13.34M18.24%-58.64M67.13%-29.24M32.90%-71.72M
Cash flow from financing activities
New borrowing 56.33%605.77M-20.93%251.05M-29.58%387.5M12.19%317.5M35.37%550.25M-22.95%283M50.55%406.49M116.05%367.29M41.78%270M0.00%170M
Refund -10.32%-357.68M-25.55%-109.63M24.31%-324.22M39.73%-87.32M-47.70%-428.34M28.24%-144.89M-56.76%-290M-38.29%-201.9M-9.28%-185M-4.44%-146M
Dividends paid - financing 31.34%-35.4M-23.33%-21.32M-70.16%-51.55M-44.24%-17.29M-77.08%-30.3M-45.46%-11.99M41.07%-17.11M-23.96%-8.24M-56.11%-29.04M-12.01%-6.65M
Absorb investment income -67.23%3M-29.58%2.85M215.62%9.15M65.24%4.04M-87.59%2.9M-89.53%2.45M89.24%23.36M450.33%23.36M-64.55%12.35M-4.18%4.25M
Other items of the financing business -225.49%-119.59M-413.20%-113.15M257.06%95.3M37.76%-22.05M39.74%-60.68M58.60%-35.43M-66.30%-100.69M-79.98%-85.56M---60.55M-1,501.60%-47.54M
Net cash from financing operations -17.28%96.11M-94.98%9.79M243.38%116.18M109.24%194.88M53.42%33.83M-1.90%93.14M184.12%22.05M466.00%94.95M-79.23%7.76M-200.80%-25.94M
Effect of rate -94.49%4.33K-70.50%13.07K302.72%78.46K310.66%44.31K84.39%-38.7K-118.02%-21.04K60.97%-248.02K115.39%116.74K-157.04%-635.43K-171.83%-758.6K
Net Cash 109.17%146.13M-95.06%4.27M715.09%69.86M24.36%86.45M-132.32%-11.36M90.85%69.52M258.90%35.14M137.01%36.42M56.18%-22.11M-20.85%-98.42M
Begining period cash 37.02%258.6M37.02%258.6M-5.68%188.73M-5.68%188.73M21.30%200.09M21.30%200.09M-11.82%164.95M-11.82%164.95M-21.25%187.07M-21.25%187.07M
Cash at the end 56.51%404.72M-4.47%262.87M37.02%258.6M2.07%275.18M-5.68%188.73M33.88%269.61M21.30%200.09M127.17%201.38M-11.82%164.95M-43.21%88.64M
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified Opinion--Unqualified Opinion--Qualified opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Lixin Certified Public Accountants (special general partnership)--Lixin Certified Public Accountants (special general partnership)--Lixin Certified Public Accountants (special general partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg